Developing and validating SARS‐CoV‐2 assays for nonhuman primate surveillance

Introduction In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its nonhuman primate colony. Materials/Methods To detect antiviral antibodies, multi‐antigen assays were developed and validated on enzyme immunoassay...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical primatology Vol. 51; no. 5; pp. 264 - 269
Main Authors: Yee, JoAnn, Carpenter, Amanda, Nham, Peter, Halley, Bryson, Van Rompay, Koen K. A., Roberts, Jeffrey
Format: Journal Article
Language:English
Published: Denmark Wiley Subscription Services, Inc 01.10.2022
John Wiley and Sons Inc
Subjects:
ISSN:0047-2565, 1600-0684, 1600-0684
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Introduction In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its nonhuman primate colony. Materials/Methods To detect antiviral antibodies, multi‐antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT‐PCR was also performed. Results/Conclusion Using a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory‐developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen‐reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.
AbstractList IntroductionIn early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its nonhuman primate colony.Materials/MethodsTo detect antiviral antibodies, multi‐antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT‐PCR was also performed.Results/ConclusionUsing a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory‐developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen‐reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.
In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS-CoV-2 infection in its nonhuman primate colony. To detect antiviral antibodies, multi-antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT-PCR was also performed. Using a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory-developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen-reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.
Introduction In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its nonhuman primate colony. Materials/Methods To detect antiviral antibodies, multi‐antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT‐PCR was also performed. Results/Conclusion Using a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory‐developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen‐reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.
In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS-CoV-2 infection in its nonhuman primate colony.INTRODUCTIONIn early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS-CoV-2 infection in its nonhuman primate colony.To detect antiviral antibodies, multi-antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT-PCR was also performed.MATERIALS/METHODSTo detect antiviral antibodies, multi-antigen assays were developed and validated on enzyme immunoassay and multiplex microbead immunofluorescent assay (MMIA) platforms. To detect viral RNA, RT-PCR was also performed.Using a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory-developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen-reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.RESULTS/CONCLUSIONUsing a 4plex, antibody was identified in 16/16 experimentally infected animals; and specificity for spike, nucleocapsid, receptor binding domain, and whole virus antigens was 95.2%, 93.8%, 94.3%, and 97.1%, respectively on surveillance samples. Six laboratories compared this MMIA favorably with nine additional laboratory-developed or commercially available assays. Using a screen and confirm algorithm, 141 of the last 2441 surveillance samples were screen-reactive requiring confirmatory testing. Although 35 samples were reactive to either nucleocapsid or spike; none were reactive to both. Over 20 000 animals have been tested and no spontaneous infections have so far been confirmed across the NIH sponsored National Primate Research Centers.
Author Carpenter, Amanda
Roberts, Jeffrey
Nham, Peter
Halley, Bryson
Yee, JoAnn
Van Rompay, Koen K. A.
AuthorAffiliation 2 Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine University of California, Davis Davis California USA
1 Primate Assay Laboratory, California National Primate Research Center University of California, Davis Davis California USA
3 Department Medicine and Epidemiology, School of Veterinary Medicine University of California, Davis Davis California USA
AuthorAffiliation_xml – name: 2 Department of Pathology, Microbiology & Immunology, School of Veterinary Medicine University of California, Davis Davis California USA
– name: 3 Department Medicine and Epidemiology, School of Veterinary Medicine University of California, Davis Davis California USA
– name: 1 Primate Assay Laboratory, California National Primate Research Center University of California, Davis Davis California USA
Author_xml – sequence: 1
  givenname: JoAnn
  orcidid: 0000-0002-5514-9836
  surname: Yee
  fullname: Yee, JoAnn
  email: joyee@ucdavis.edu
  organization: University of California, Davis
– sequence: 2
  givenname: Amanda
  surname: Carpenter
  fullname: Carpenter, Amanda
  organization: University of California, Davis
– sequence: 3
  givenname: Peter
  surname: Nham
  fullname: Nham, Peter
  organization: University of California, Davis
– sequence: 4
  givenname: Bryson
  surname: Halley
  fullname: Halley, Bryson
  organization: University of California, Davis
– sequence: 5
  givenname: Koen K. A.
  surname: Van Rompay
  fullname: Van Rompay, Koen K. A.
  organization: University of California, Davis
– sequence: 6
  givenname: Jeffrey
  surname: Roberts
  fullname: Roberts, Jeffrey
  organization: University of California, Davis
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35794847$$D View this record in MEDLINE/PubMed
BookMark eNp9kctu1DAUhi1URKeFBS-AIrGBxbTH1yQbpGq4q4hLga114nhajxJ7aieDZscj8Iw8CU6nVFAJvDiW5e_8_o__A7Lng7eEPKRwRPM6XvXrI8oUiDtkRhXAHFQl9sgMQJRzJpXcJwcprQCAi1rcI_tclrWoRDkjH5_bje3C2vnzAn1bbLBzLQ7T8ezk09nP7z8W4WuurMCUcJuKZYhFfv5i7NEX6-h6HGyRxrixruvQG3uf3F1il-yD6_2QfHn54vPi9fz0_as3i5PTuRGCi1xNI5bM1BRFU6KopBVgVWNqVinkSNEawykVrVTQ2rZtQWHTGFM3nKIBfkie7XTXY9Pb1lg_ROz0laW41QGd_vvGuwt9Hja65hI4k1ngybVADJejTYPuXTJ2msKGMWmmKgWykkxl9PEtdBXG6PN4mpWUlVALOVGP_nR0Y-X3b2fg6Q4wMaQU7fIGoaCnJHVOUl8lmdnjW6xxQw4mTMO47n8d31xnt_-W1m_ffdh1_AJCMbIz
CitedBy_id crossref_primary_10_1002_ajp_23654
crossref_primary_10_1038_s41598_023_30473_7
Cites_doi 10.1016/j.jviromet.2009.07.030
10.1038/s41564-020-0761-6
10.1002/jmv.25855
10.1080/21505594.2021.1996519
10.1016/j.mayocp.2020.04.004
10.1111/jmp.12483
10.1080/01652176.2020.1867776
10.1128/Spectrum.01397-21
10.1038/s41467-020-18450-4
10.1038/s41467-020-20642-x
10.1038/s41586-020-2324-7
10.1111/jmp.12209
ContentType Journal Article
Copyright 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright © 2022 John Wiley & Sons A/S
Copyright_xml – notice: 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
– notice: Copyright © 2022 John Wiley & Sons A/S
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
5PM
DOI 10.1111/jmp.12604
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Zoology
DocumentTitleAlternate YEE et al
EISSN 1600-0684
EndPage 269
ExternalDocumentID PMC9350325
35794847
10_1111_jmp_12604
JMP12604
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIH Office of the Director
  funderid: CNPRC P51OD011107; U42 OD010426‐15
– fundername: NIH HHS
  grantid: U42 OD010990
– fundername: NIH HHS
  grantid: U42 OD010426
– fundername: NIH HHS
  grantid: P51 OD011107
– fundername: ;
  grantid: CNPRC P51OD011107; U42 OD010426‐15
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
29L
30W
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HVLQZ
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PQQKQ
Q.N
Q11
QB0
R.K
RKO
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WQJ
WRC
WVDHM
WXI
WXSBR
XG1
YFH
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
AAMMB
AAYXX
ACQXL
AEFGJ
AEYWJ
AFSIO
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c4434-c4cb4f2c91a4b7a485e40e6bc9286a3a1aecc3114d560deddd06abbcc9b31ac03
IEDL.DBID DRFUL
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000821390500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0047-2565
1600-0684
IngestDate Tue Nov 04 01:51:43 EST 2025
Sun Nov 09 12:24:13 EST 2025
Sat Nov 29 15:01:43 EST 2025
Wed Feb 19 02:05:34 EST 2025
Sat Nov 29 02:37:55 EST 2025
Tue Nov 18 21:43:06 EST 2025
Wed Jan 22 16:24:06 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords RT-PCR
diagnostic testing algorithm
antibody
Language English
License 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4434-c4cb4f2c91a4b7a485e40e6bc9286a3a1aecc3114d560deddd06abbcc9b31ac03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-5514-9836
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC9350325
PMID 35794847
PQID 2712709456
PQPubID 2034241
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_9350325
proquest_miscellaneous_2686058526
proquest_journals_2712709456
pubmed_primary_35794847
crossref_primary_10_1111_jmp_12604
crossref_citationtrail_10_1111_jmp_12604
wiley_primary_10_1111_jmp_12604_JMP12604
PublicationCentury 2000
PublicationDate October 2022
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: October 2022
PublicationDecade 2020
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Hoboken
PublicationTitle Journal of medical primatology
PublicationTitleAlternate J Med Primatol
PublicationYear 2022
Publisher Wiley Subscription Services, Inc
John Wiley and Sons Inc
Publisher_xml – name: Wiley Subscription Services, Inc
– name: John Wiley and Sons Inc
References 2021; 9
2020; 49
2020; 5
2020; 585
2009; 162
2020; 11
2021; 12
2020; 95
2021; 41
2020; 92
2016; 45
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – volume: 162
  start-page: 148
  issue: 1–2
  year: 2009
  end-page: 154
  article-title: Development of a generic real‐time PCR assay for simultaneous detection of proviral DNA of simian Betaretrovirus serotypes 1, 2, 3, 4 and 5 and secondary uniplex assays for specific serotype identification
  publication-title: J Virol Methods
– volume: 585
  start-page: 268
  year: 2020
  end-page: 272
  article-title: Respiratory disease in rhesus macaques inoculated with SARS‐CoV‐2
  publication-title: Nature
– volume: 95
  start-page: 1127
  year: 2020
  end-page: 1129
  article-title: COVID‐19 testing: the threat of false‐negative results
  publication-title: Mayo Clin Proc
– volume: 41
  start-page: 50
  issue: 1
  year: 2021
  end-page: 60
  article-title: SARS‐CoV‐2 infection in farmed minks, associated zoonotic concerns, and importance of the one health approach during the ongoing COVID‐19 pandemic
  publication-title: Vet Q
– volume: 12
  start-page: 2777
  issue: 1
  year: 2021
  end-page: 2786
  article-title: Understanding the prevalence of SARS‐CoV‐2 (COVID‐19) exposure in companion, captive, wild, and farmed animals
  publication-title: Virulence
– volume: 11
  start-page: 4704
  year: 2020
  article-title: A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity
  publication-title: Nat Commun
– volume: 49
  start-page: 322
  year: 2020
  end-page: 331
  article-title: SARS‐CoV‐2 surveillance for a non‐human primate breeding research facility
  publication-title: J Med Primatol
– volume: 12
  start-page: 541
  year: 2021
  article-title: SARS‐CoV‐2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques
  publication-title: Nat Commun
– volume: 92
  start-page: 1755
  year: 2020
  end-page: 1756
  article-title: False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: rather than recurrence
  publication-title: J Med Virol
– volume: 5
  start-page: 1299
  year: 2020
  end-page: 1305
  article-title: Analytical sensitivity and efficiency comparisons of SARS‐CoV‐2 RT–qPCR primer–probe sets
  publication-title: Nat Microbiol
– volume: 9
  issue: 3
  year: 2021
  article-title: SARS‐CoV‐2 infection of Rhesus Macaques treated early with human COVID‐19 convalescent plasma
  publication-title: Microbiol Spectr
– volume: 45
  start-page: 55
  issue: 2
  year: 2016
  end-page: 78
  article-title: Specific pathogen free macaque colonies: a review of principles and recent advances for viral testing and colony management
  publication-title: J Med Primatol
– ident: e_1_2_8_10_1
– ident: e_1_2_8_20_1
  doi: 10.1016/j.jviromet.2009.07.030
– ident: e_1_2_8_12_1
  doi: 10.1038/s41564-020-0761-6
– ident: e_1_2_8_16_1
– ident: e_1_2_8_7_1
  doi: 10.1002/jmv.25855
– ident: e_1_2_8_14_1
  doi: 10.1080/21505594.2021.1996519
– ident: e_1_2_8_8_1
  doi: 10.1016/j.mayocp.2020.04.004
– ident: e_1_2_8_11_1
– ident: e_1_2_8_17_1
– ident: e_1_2_8_19_1
– ident: e_1_2_8_2_1
  doi: 10.1111/jmp.12483
– ident: e_1_2_8_15_1
  doi: 10.1080/01652176.2020.1867776
– ident: e_1_2_8_6_1
  doi: 10.1128/Spectrum.01397-21
– ident: e_1_2_8_18_1
– ident: e_1_2_8_4_1
  doi: 10.1038/s41467-020-18450-4
– ident: e_1_2_8_5_1
  doi: 10.1038/s41467-020-20642-x
– ident: e_1_2_8_3_1
  doi: 10.1038/s41586-020-2324-7
– ident: e_1_2_8_9_1
  doi: 10.1111/jmp.12209
– ident: e_1_2_8_13_1
SSID ssj0003494
Score 2.294178
Snippet Introduction In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its...
In early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS-CoV-2 infection in its nonhuman primate...
IntroductionIn early 2020, the California National Primate Research Center implemented surveillance to address the threat of SARS‐CoV‐2 infection in its...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 264
SubjectTerms Animals
Antibodies, Viral
antibody
Antigens
Antiviral drugs
COVID-19 - diagnosis
diagnostic testing algorithm
Enzyme immunoassay
Laboratories
Microspheres
Nucleocapsids
Original
RNA, Viral
RT‐PCR
SARS-CoV-2
Sensitivity and Specificity
Severe acute respiratory syndrome coronavirus 2
Surveillance
Title Developing and validating SARS‐CoV‐2 assays for nonhuman primate surveillance
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjmp.12604
https://www.ncbi.nlm.nih.gov/pubmed/35794847
https://www.proquest.com/docview/2712709456
https://www.proquest.com/docview/2686058526
https://pubmed.ncbi.nlm.nih.gov/PMC9350325
Volume 51
WOSCitedRecordID wos000821390500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1600-0684
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0003494
  issn: 0047-2565
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fS-QwEB90PcEX9c5_e_4hd9zDvVTaJG1T7knURcQTT09Z7qUkaYoLbnfZ7gq--RH8jPdJbpJ2i4seCL6ElkxJmsxMJpnMbwC-0SQPmDSBF8U59ZApIk_kXHl5prRiygjmot5vzuLzc9HtJhdz8GMaC1PhQzQHblYynL62Ai5V-VzI-8P9AK1xPg8LFPmWt2Dh6LJzfdYoYou8UjmYLRhBFNbAQu4iz_Tj2eXohY358qrkcxPWrUGdlXf1fhWWa9OTHFS88hHmTPEJFv8M3MH6Gvw6auKniCwygizYs7EP-Hp1cHn19_HpcHCDJSVob8uHkqC5S4pB4bL8kaFFrRgbUk5G98ZmMkJmWofrzvHvwxOvTrjgac4Zx1IrnlOdBJKrWHIRGu6bSOmEikgyGUiccIY7qAztpMxkWeZHUimtE8UCqX22AS1s12wB4QxrkkDYuFxOtS9RDxjBhZJc5sKP2_B9Ou6prtHIbVKMu7TZlfSHqRuhNnxtSIcVBMdrRDvTyUtrKSxTGlu_eoI2Yhu-NNUoP9YpIgszmCBNJKxnOKRIs1nNddMKC1Fb4fLdhniGCxoCi809W1P0bh1Gd8JCn9EQf9Nxwf87np7-vHAPn99Oug1L1EZhuDuFO9AajyZmFz7o-3GvHO3BfNwVe7Uw_AM6nw-S
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED9BGdpe9sG-OmDz0B72kimxncSReEGwim2lYi2gipfIdhxRiaZVP5D2tj9hfyN_CWcnjagYEhIvViJfZMe-O599vt8BfKFJHjBpAi-Kc-ohU0SeyLny8kxpxZQRzEW9n7XjTkf0-8nxCuwuYmFKfIj6wM1KhtPXVsDtgfRtKR-OvwVojvNVWOPIRmED1g66rdN2rYkt9ErpYbZoBFFYIQu5mzyLj5fXoztG5t27krdtWLcItV48rvsv4XllfJK9kltewYopNmD9fOSO1l_D74M6gorIIiPIhAMb_YCvvb1u7_rvv_3RGZaUoMUt_0wJGrykGBUuzx8ZW9yKmSHT-eTK2FxGyE5v4LT1_WT_0KtSLniac8ax1IrnVCeB5CqWXISG-yZSOqEikkwGEqec4R4qQ0spM1mW-ZFUSutEsUBqn72FBrZr3gPhDGuSQNjIXE61L1ETGMGFklzmwo-b8HUx8Kmu8MhtWozLtN6XDMepG6Em7NSk4xKE439EW4vZSys5nKY0tp71BK3EJnyuq1GCrFtEFmY0R5pIWN9wSJHmXTnZdSssRH2FC3gT4iU2qAksOvdyTTG4cCjdCQt9RkP8TccG93c8_Xl07B4-PJz0Ezw9PDlqp-0fnV-b8IzamAx3w3ALGrPJ3GzDE301G0wnHyuZuAECBhKa
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB6VFlAvUKClC30YxIFLUGI7iS1xqbpd8diulpZWFZfIdhyxEs1G-6jUW38Cv5FfwtjJRl0VJCQuViJPZMeeGY89nm8A3lBZREzZKEjSggbIFEkgCq6DItdGM20F81Hv5_10MBAXF3K4Au8XsTA1PkR74OYkw-trJ-C2yovbUn5ZvYvQHOf3YI3HMkGxXOue9M76rSZ20Cu1h9mhESRxgyzkb_IsPl5ej-4YmXfvSt62Yf0i1Hv8f93fgEeN8UkOam55Aiu2fAoPvo390foz-NJtI6iIKnOCTDhy0Q_4enpwcvrr5ufh-BxLStDiVtdTggYvKcelz_NHKodbMbNkOp9cWZfLCNlpE856R18PPwRNyoXAcM44lkbzghoZKa5TxUVseWgTbSQViWIqUjjlDPdQOVpKuc3zPEyU1sZIzSJlQrYFq9iu3QbCGdbISLjIXE5NqFATWMGFVlwVIkw78HYx8Jlp8MhdWowfWbsvuawyP0IdeN2SVjUIx5-IdhazlzVyOM1o6jzrEq3EDrxqq1GCnFtElXY8R5pEON9wTJHmeT3ZbSssRn2FC3gH0iU2aAkcOvdyTTn67lG6JYtDRmP8Tc8Gf-949ul46B9e_DvpPjwcdntZ_-Pg80tYpy4kw18w3IHV2WRud-G-uZqNppO9RiR-A3TxEhU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Developing+and+validating+SARS-CoV-2+assays+for+nonhuman+primate+surveillance&rft.jtitle=Journal+of+medical+primatology&rft.au=Yee%2C+JoAnn&rft.au=Carpenter%2C+Amanda&rft.au=Nham%2C+Peter&rft.au=Halley%2C+Bryson&rft.date=2022-10-01&rft.issn=1600-0684&rft.eissn=1600-0684&rft.volume=51&rft.issue=5&rft.spage=264&rft_id=info:doi/10.1111%2Fjmp.12604&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0047-2565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0047-2565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0047-2565&client=summon